Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 32.53% vs 14.08% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 49.18% vs 20.19% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 67.03% vs 5.35% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is -33.92% vs -43.69% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Ajanta Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 10.34% vs 14.37% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 32.53% vs 14.08% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 16.13% vs 25.32% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 49.18% vs 20.19% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 29.27% vs 27.04% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 67.03% vs 5.35% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -29.56% vs 34.75% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -33.92% vs -43.69% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025